Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT

Nektar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-118.96M -276.06M -368.2M -523.84M
Depreciation & Amortization
4.39M 7.82M 13.03M 14.15M
Stock-Based Compensation
21.61M 33.39M 57.32M 94.67M
Other Working Capital
-6.36M -22.39M -15.72M -23.27M
Other Non-Cash Items
-76.51M 62.19M -9.36M 17.41M
Deferred Income Tax
n/a -140K 2.71M 8.02M
Change in Working Capital
-6.24M -19.8M 492K -23.08M
Operating Cash Flow
-175.71M -192.61M -304.01M -412.66M
Capital Expenditures
-1.47M -865K -5.68M -14.99M
Cash Acquisitions
n/a n/a 13.2M -217.77M
Purchase of Investments
-261.71M -511.7M -467.91M -960.69M
Sales Maturities Of Investments
340.36M 650.88M 826.23M 1.18B
Other Investing Acitivies
65.39M 1.25M n/a 217.77M
Investing Cash Flow
142.57M 139.56M 365.83M 202.78M
Debt Repayment
15M n/a n/a n/a
Common Stock Repurchased
-3M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
30.12M n/a 750K 3M
Financial Cash Flow
42.12M 30K 1.51M 36.24M
Net Cash Flow
8.97M -52.95M 63.01M -173.74M
Free Cash Flow
-177.18M -193.47M -309.68M -427.65M